Skip to content
My WebMD Sign In, Sign Up

Cancer Health Center

Font Size

Anemia Drugs Up Cancer Death Risk

Study Shows More Deaths, Blood Clots in Cancer Patients Taking Procrit, Epogen, Aranesp

Whither Procrit, Epogen, Aranesp? continued...

"I think the fear among oncologists is that the ESAs may just be removed from all cancer indications, and I don't know that is the best decision," he says. "You begin with patients with severe cancers who have severe treatment-related side effects. You have to balance the benefits of ESAs against the risks of what could happen to a patient's tumors if you use the drugs."

Bennett, Lai, and colleagues report their findings in the Feb. 27 issue of The Journal of the American Medical Association.

1|2|3

Today on WebMD

Building a Support System
Blog
cancer fighting foods
SLIDESHOW
 
precancerous lesions slideshow
SLIDESHOW
quit smoking tips
SLIDESHOW
 
Jennifer Goodman Linn self-portrait
Blog
what is your cancer risk
HEALTH CHECK
 
colorectal cancer treatment advances
Video
breast cancer overview slideshow
SLIDESHOW
 
prostate cancer overview
SLIDESHOW
lung cancer overview slideshow
SLIDESHOW
 
ovarian cancer overview slideshow
SLIDESHOW
Actor Michael Douglas
Article